Saturday, December 5th, 2015

Session: 618. Acute Lymphoblastic Leukemia:

Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Poster I

Integrated DNA/RNA Profiling for Somatic Alterations in Adult B-cell ALL

Session Time / Loc.: 9am-7:30pm ET / Hall A

Presentation Time: 5:30-7:30pm ET

Publication Number: 1422

Presenter: Franck Rapaport, Ph.D., Computational Research Leader, Leukemia Center, Memorial Sloan-Kettering Cancer Center

Collaborators: Memorial Sloan-Kettering Cancer Center, Montefiore Medical Center, Mayo Clinic, University of Pennsylvania, Shaare Zedek Medical Center, Northwestern University Feinberg School of Medicine, Weill Cornell Medical College

[View Abstract]

Session: 617. Acute Myeloid Leukemia:

Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Omics-based Approaches for the Identification of Novel Genetic Modalities in AML

Genomic and Proteomic Analysis of Primary Chemoresistance and Induction Failure in Acute Myeloid Leukemia

Session Time / Loc.: 12-1:30pm ET / Tangerine 3 (WF3-4), Lvl. 2

Presentation Time: 12:45pm ET

Publication Number: 88

Presenter: Fiona Brown, Ph.D., Research Fellow, Memorial Sloan-Kettering Cancer Center

Collaborators: Memorial Sloan-Kettering Cancer Center, Dana-Farber Cancer Institute, Children’s Hospital Boston, Children’s Oncology Group, Fred Hutchinson Cancer Research Center, The University of Texas MD Anderson Cancer Center, The Ohio State University Comprehensive Cancer Center, Harvard Medical School

[View Abstract]

Sunday, December 6th, 2015

Session: 622. Non-Hodgkin Lymphoma:

Biology, Excluding Therapy: Poster II

Predictive and Prognostic Significance of Comprehensive Genomic Profiling in Patients with Diffuse Large B-cell Lymphoma

Poster Display Time/ Loc.: 9am-8pm ET / Hall A2-A

Presentation Time: 6-8pm ET

Publication Number: 2651

Presenter: Jie He, Senior Manager, Computational Biology Analysis, Foundation Medicine

[View Abstract]

 

Session: 622. Non-Hodgkin Lymphoma:

Biology, Excluding Therapy: Poster III

Defining the Incidence and Clinical Impact of Genomic Alterations Across Different Histologic Types of Lymphoma Using a Clinically Validated Comprehensive Targeted Sequencing Assay

Poster Display Time/ Loc.: 9am-8pm ET / Hall A2-A3, Lvl. 2

Presentation Time: 6-8pm ET

Publication Number: 2668

Presenter: Connie Lee Batlevi, M.D., Ph.D., Hematology/Oncology Fellow, Memorial Sloan-Kettering Cancer Center

Collaborator: Memorial Sloan-Kettering Cancer Center

[View Abstract]

Session: 651. Myeloma:

Biology and Pathophysiology, Excluding Therapy: Novel Technologies to Evaluate Biology and Prognosis

Comprehensive Genomic Profiling of Multiple Myeloma in the Course of Clinical Care Identifies Targetable and Prognostically Significant Genomic Alterations

Session Time/ Loc.: 4:30-6pm ET/W224ABEF Lvl. 2

Presentation Time: 5:45pm ET

Publication Number: 369

Presenter: Christopher Heuck, M.D., Assistant Professor of Medicine, Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences

Collaborator: Myeloma Institute for Research and Therapy

[View Abstract]

Monday, December 7th, 2015

622. Non-Hodgkin Lymphoma:

Biology, Excluding Therapy: Poster III

Comprehensive Genomic Profiling (CGP) of Angioimmunoblastic T-cell Lymphoma (AITL) to Prospectively Inform Diagnosis and Clinical Management

Session Time/ Loc.: 6-8pm ET/Hall A2-A3, Lvl. 2

Presentation Time: 10am-8pm ET

Publication Number: 3898

Presenter: Tariq Mughal, M.D., Vice President, Medical Affairs, Foundation Medicine

Collaborators: Memorial Sloan-Kettering Cancer Center, Tufts University Medical Center

[View Abstract]

Session: 635. Myeloproliferative Syndromes:

Basic Science I

Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms

Session Time/ Loc.: 7am ET/W331

Presentation Time: 7-8:30am ET

Abstract Number: 481

Presenter: Benjamin Durham, M.D., Research Fellow, Memorial Sloan-Kettering Cancer Center

Collaborator: Memorial Sloan-Kettering Cancer Center  

[View Abstract]